Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12622001479796
ACTRN12622001479796
Not yet recruiting
未知

Diagnostic performance of diffusion-weighted MRI compared to laparoscopy in predicting feasibility of complete cytoreduction in advanced ovarian, fallopian tube and primary peritoneal cancer.

Chris O'Brien Lifehouse (Sydney Local Health District)0 sites50 target enrollmentNovember 24, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOvarian, fallopian tube and primary peritoneal cancerCancer - Ovarian and primary peritoneal

Overview

Phase
未知
Intervention
Not specified
Conditions
Ovarian, fallopian tube and primary peritoneal cancer
Sponsor
Chris O'Brien Lifehouse (Sydney Local Health District)
Enrollment
50
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 24, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Chris O'Brien Lifehouse (Sydney Local Health District)

Eligibility Criteria

Inclusion Criteria

  • •1\) Age greater than or equal to 18 years old
  • •2\) FIGO stage 3 ovarian cancer
  • •3\) Histologically or cytologically proven primary epithelial ovarian, primary peritoneal or fallopian tube carcinoma (including serous papillary adenocarcinoma, adenocarcinoma and endometrioid adenocarcinoma)
  • •4\) Willingness to provide written informed consent and participate in the study

Exclusion Criteria

  • •1\) Diagnosis other than ovarian cancer
  • •2\) Previous abdominal malignancy or tuberculosis
  • •3\) Severe claustrophobia
  • •4\) MR (magnetic resonance) contrast allergy
  • •5\) Hip replacement or spinal hardware
  • •6\) Renal failure of either acute or chronic nature which precludes contrast administration

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Diagnostic accuracy of MRI, diffusion-weighted MRI, FDGPET/CT and Fluoro-ethyl-choline PET/CT in the detection of lymph node metastases in surgically staged endometrial and cervical carcinomaTopic: National Cancer Research NetworkSubtopic: Gynaecological CancerDisease: Cervix, EndometriumCancerMalignant neoplasm of cervix uteri
ISRCTN84527805Barts and The London Trust (UK)147
Active, not recruiting
Phase 1
MAPPINGEndometrial and Cervical CancerTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2011-001290-78-GBBarts Health NHS Trust150
Recruiting
Not Applicable
*Predictive value of Diffusion weighted MRI in patients with HNSCC treated by (chemo)radiotherapy (PREDICT study)*head and neck squamous cell carcinomathroat cancer1002765510046304
NL-OMON56355niversitair Medisch Centrum Utrecht120
Recruiting
Not Applicable
Accuracy of diffusion weighted MRI in detecting residual tumor in patients conservatively treated for cervical carcinoma.cervical carcinoma10013364
NL-OMON39623Erasmus MC, Universitair Medisch Centrum Rotterdam120
Recruiting
Not Applicable
MRI-guided identification of response to (chemo)radiotherapy in patients with head and neck cancerHead and Neck Squamous Cell Carcinoma (HNSCC)Oropharyngeal cancerCancer of the oral cavityHypopharyngeal cancerLaryngeal cancerHoofd-hals kanker
NL-OMON24896niversity Medical Center Utrecht100